Site specific gene delivery in the cardiovascular system

Area of Science:

• Cardiovascular Medicine
• Gene Therapy
• Biotechnology

Background:

• Gene therapy faces challenges like vector toxicity and immune responses, limiting its application in cardiovascular disease.
• Cardiovascular diseases are a leading cause of death, necessitating innovative treatment strategies beyond current surgical interventions.

Purpose of the Study:

• To review investigations supporting site-specific cardiovascular gene therapy for improved efficacy and reduced systemic adverse effects.
• To demonstrate proof of principle for localized gene therapy in heart valve disease, gene delivery stents, and cardiac arrhythmias.

Main Methods:

• Immobilizing gene vectors on prosthetic heart valve leaflets for localized therapeutic modification.
• Utilizing vascular stents as gene delivery systems to prevent in-stent restenosis and treat vascular disease.
• Investigating localized gene therapy in animal models to correct ion channel mutations causing cardiac arrhythmias.

Main Results:

• Gene vectors on prosthetic heart valves enable therapeutic genetic modification of surrounding host cells.
• Gene-eluting stents effectively prevent post-stenting reobstruction and treat underlying vascular conditions.
• Localized gene therapy successfully treated atrial arrhythmias in animal studies by targeting ion channel mutations.

Conclusions:

• Site-specific cardiovascular gene therapy is a viable strategy to optimize treatment outcomes and mitigate gene vector-related risks.
• This approach shows significant potential for treating heart valve disease, preventing in-stent restenosis, and managing cardiac arrhythmias.